203 related articles for article (PubMed ID: 15983352)
1. Age and A1C are important clinical predictors of continuous subcutaneous insulin infusion efficacy in type 1 diabetic patients.
Lepore G; Dodesini AR; Nosari I; Trevisan R
Diabetes Care; 2005 Jul; 28(7):1834-5. PubMed ID: 15983352
[No Abstract] [Full Text] [Related]
2. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.
Lepore G; Dodesini AR; Nosari I; Trevisan R
Diabetes Care; 2003 Apr; 26(4):1321-2. PubMed ID: 12663625
[No Abstract] [Full Text] [Related]
3. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
[TBL] [Abstract][Full Text] [Related]
4. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.
Retnakaran R; Hochman J; DeVries JH; Hanaire-Broutin H; Heine RJ; Melki V; Zinman B
Diabetes Care; 2004 Nov; 27(11):2590-6. PubMed ID: 15504991
[TBL] [Abstract][Full Text] [Related]
5. Sustained benefits of continuous subcutaneous insulin infusion.
Hughes CR; McDowell N; Cody D; Costigan C
Arch Dis Child; 2012 Mar; 97(3):245-7. PubMed ID: 21109506
[TBL] [Abstract][Full Text] [Related]
6. Similar A1C outcomes in type 1 diabetic patients undergoing intensive diabetes management with preprandial rapid-acting insulin and either CSII or glargine.
Harmel AP; Mathur R
Diabetes Care; 2004 Jan; 27(1):272-3. PubMed ID: 14694001
[No Abstract] [Full Text] [Related]
7. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c: response to Retnakaran et al.
Blumer I
Diabetes Care; 2005 Mar; 28(3):763; author reply 763-4. PubMed ID: 15735237
[No Abstract] [Full Text] [Related]
8. Assessment of glycemic variability in continuous subcutaneous insulin infusion therapy in type 1 diabetes related to anthropometry and complication status.
Mehdi SK; Hatfield E; Dornhorst A; Oliver NS
J Diabetes Sci Technol; 2009 Sep; 3(5):1227-8. PubMed ID: 20144442
[No Abstract] [Full Text] [Related]
9. Use of continuous intravenous insulin infusion in type 1 diabetic pregnancy complicated by nephrotic syndrome.
Dudding S; Whitelaw D
Diabetes Res Clin Pract; 2011 Jul; 93(1):e53-6. PubMed ID: 21543130
[TBL] [Abstract][Full Text] [Related]
10. Severe autonomic neuropathy treated with subcutaneous insulin infusion.
Prendergast JJ; Aubry W
Diabetes Care; 1996 Jan; 19(1):90. PubMed ID: 8720543
[No Abstract] [Full Text] [Related]
11. Role of emerging new technologies.
Garg SK
Diabetes Technol Ther; 2008 Oct; 10(5):413-4. PubMed ID: 18715219
[No Abstract] [Full Text] [Related]
12. Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine.
Fahlén M; Eliasson B; Odén A
Diabet Med; 2005 Apr; 22(4):382-6. PubMed ID: 15787660
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Danish adolescent diabetic patients with CSII - a matched study to MDI.
Johannesen J; Eising S; Kohlwes S; Riis S; Beck M; Carstensen B; Bendtson I; Nerup J
Pediatr Diabetes; 2008 Feb; 9(1):23-8. PubMed ID: 18211633
[TBL] [Abstract][Full Text] [Related]
14. The effect of socioeconomic deprivation on efficacy of continuous subcutaneous insulin infusion: a retrospective paediatric case-controlled survey.
Senniappan S; Hine P; Tang W; Campbell J; Bone M; Sankar V; Robinson M; Smith C; Cooper C; Amin R;
Eur J Pediatr; 2012 Jan; 171(1):59-65. PubMed ID: 21594576
[TBL] [Abstract][Full Text] [Related]
15. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
Doyle EA; Weinzimer SA; Steffen AT; Ahern JA; Vincent M; Tamborlane WV
Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
[TBL] [Abstract][Full Text] [Related]
16. Bolus calculator settings in well-controlled type 1 diabetes patients (glycated hemoglobin < 7%) treated with insulin pumps.
Matejko B; Grzanka M; Kieć-Wilk B; Małecki MT; Klupa T
J Diabetes Sci Technol; 2013 May; 7(3):800-1. PubMed ID: 23759415
[No Abstract] [Full Text] [Related]
17. Increased Usage of Insulin Pump Functions Not Associated With Improved HbA1c in Children and Adolescents With Type 1 Diabetes Mellitus.
Sandberg H; Anderberg P; Forssell H; Ovhed I; Berglund J
J Diabetes Sci Technol; 2016 Jul; 10(4):997-8. PubMed ID: 26721525
[No Abstract] [Full Text] [Related]
18. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
19. Effect of short-term iPRO continuous glucose monitoring on hemoglobin A1c levels in clinical practice.
Pepper GM; Steinsapir J; Reynolds K
Diabetes Technol Ther; 2012 Aug; 14(8):654-7. PubMed ID: 22690923
[TBL] [Abstract][Full Text] [Related]
20. Insulin therapy in children and adolescents.
Tamborlane WV; Sikes KA
Endocrinol Metab Clin North Am; 2012 Mar; 41(1):145-60. PubMed ID: 22575411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
